GITTO, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.491
EU - Europa 2.106
AS - Asia 643
OC - Oceania 25
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 6.281
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.484
RU - Federazione Russa 962
PL - Polonia 327
IT - Italia 312
IE - Irlanda 276
HK - Hong Kong 214
SG - Singapore 163
SE - Svezia 108
CN - Cina 106
JO - Giordania 55
IN - India 52
ID - Indonesia 33
FI - Finlandia 32
AU - Australia 25
DE - Germania 20
GB - Regno Unito 20
VN - Vietnam 16
CI - Costa d'Avorio 12
CH - Svizzera 11
FR - Francia 9
RO - Romania 9
UA - Ucraina 8
CA - Canada 6
ES - Italia 6
NL - Olanda 5
KR - Corea 2
CO - Colombia 1
CZ - Repubblica Ceca 1
EU - Europa 1
IL - Israele 1
MA - Marocco 1
MX - Messico 1
TR - Turchia 1
TZ - Tanzania 1
Totale 6.281
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.427
Fairfield 355
Warsaw 326
Dublin 276
Ashburn 156
Hong Kong 148
Singapore 143
Woodbridge 142
Lawrence 134
Seattle 129
Altamura 112
Cambridge 112
Houston 105
Chandler 82
Wilmington 81
Princeton 67
Boston 65
Moscow 61
Florence 52
Mumbai 50
Ann Arbor 43
San Diego 38
Jakarta 33
Beijing 27
Helsinki 27
Shanghai 26
Melbourne 24
Medford 16
New York 16
Milan 15
Dong Ket 14
Norwalk 14
Boardman 13
Buffalo 13
Abidjan 12
Bern 11
Bologna 11
London 10
West Jordan 10
Yubileyny 10
Falls Church 9
Hillsboro 9
Timisoara 9
Kent 8
Barcelona 6
Guangzhou 5
Lappeenranta 5
Los Angeles 5
Padova 5
Prato 5
Rome 5
Toronto 5
Modena 4
Naples 4
Osimo 4
Prescot 4
Scandicci 4
Jacksonville 3
Laurel 3
Menlo Park 3
Minerbio 3
Nanjing 3
Palermo 3
Parma 3
Phoenix 3
Pisa 3
Treviso 3
Villaricca 3
Alleghe 2
Aosta 2
Caserta 2
Castelliri 2
Hangzhou 2
Livorno 2
Nuremberg 2
Redmond 2
Saint-Fons 2
Sesto Fiorentino 2
St Petersburg 2
Talla 2
Venice 2
Washington 2
Werdau 2
Wuhan 2
Xi'an 2
Andover 1
Ankara 1
Arnsberg 1
Bogotá 1
Bovisio-Masciago 1
Bremen 1
Brno 1
Campagnola Emilia 1
Casablanca 1
Cesena 1
Chennai 1
Chiswick 1
Dar es Salaam 1
Falkenstein 1
Fiesole 1
Totale 4.584
Salva come PNG Salva come JPEG
Nome #
Transjugular Intrahepatic Portosystemic Shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: A real-life, case-control study 228
Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis 211
Low molecular weight heparin does not increase bleeding and mortality post-endoscopic variceal band ligation in cirrhotic patients 157
Assessment of Liver Fibrosis With Elastography Point Quantification vs Other Noninvasive Methods 130
Quality of life in liver transplant recipients during the Corona virus disease 19 pandemic: A multicentre study 129
The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes 117
Altered clot formation and lysis are associated with increased fibrinolytic activity in ascites in patients with advanced cirrhosis 111
Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes 106
Alcohol use disorder and liver transplant: new perspectives and critical issues 105
Super-resolution microscopy reveals an altered fibrin network in cirrhosis: The key role of oxidative stress in fibrinogen structural modifications 102
Hepatitis C virus recurrence after liver transplantation: A 10-year evaluation 99
Alcoholic and Nonalcoholic Liver Disease: Diagnostic Assessment and Therapeutic Perspectives 98
Pre-transplant diabetes predicts atherosclerotic vascular events and cardiovascular mortality in liver transplant recipients: a long-term follow-up study 95
Fatty liver index is associated to pulse wave velocity in healthy subjects: Data from the Brisighella Heart Study 94
Characterization of lymphocyte subsets in ascitic fluid and peripheral blood of decompensated cirrhotic patients with chronic hepatitis C and alcoholic liver disease: A pivotal study 92
Nonalcoholic steatohepatitis before and after liver transplant: keeping up with the times 91
Cellular and molecular mechanisms underlying liver fibrosis regression 91
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals. 89
Non-alcoholic fatty liver disease and metabolic syndrome after liver transplant 89
Gold standard assays for the monitoring of patients with chronic hepatitis C 88
Alcohol associated liver disease 2020: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF) 86
Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing 85
Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B. 81
Treatment of nonalcoholic steatohepatitis in adults: Present and future 80
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 80
Pattern of macrovascular invasion in hepatocellular carcinoma 79
The changing scenario of hepatocellular carcinoma in Italy: an update 76
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model 75
Does Metabolic Syndrome and Not the Inflammatory Load Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients? 75
Biological therapies in patients with liver disease: are they really lifesavers? 73
De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients 72
Allocation priority in non-urgent liver transplantation: An overview of proposed scoring systems 72
Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis 71
Adherence to Mediterranean diet in liver transplant recipients: a cross-sectional multicenter study 69
A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18 69
Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: a long-term follow-up study 68
Needs evaluation questionnaire for liver disease: a novel assessment of unmet needs in patients with chronic liver disease 67
Transjugular intrahepatic Porto-systemic shunt positively influences the composition and metabolic functions of the gut microbiota in cirrhotic patients 67
Oncostatin M: From Intracellular Signaling to Therapeutic Targets in Liver Cancer 66
Alcohol and viral hepatitis: A mini-review 66
Metabolic Disorders After Liver Transplantation 65
Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: Which is the winner? 65
Bioelectrical impedance vector analysis and cardiovascular performance in liver-transplanted recipients 62
Acute hepatitis B caused by a vaccine-escape HBV strain in vaccinated subject: Sequence analysis and therapeutic strategy 62
Portosystemic shunt is an effective treatment for complications of portal hypertension in hepatic myeloid metaplasia and improves nutritional status 61
Unsupervised Exercise Intervention vs. Adherence to a Mediterranean Diet Alone: The Role of Bioelectrical Impedance Vector Analysis and Cardiovascular Performance in Liver-Transplanted Recipients 61
Statin-induced, immune-mediated injury with simultaneous targeting of skeletal muscle, skin and liver 60
Impact of psychosocial status on liver transplant process 58
Familial intrahepatic cholestasis: New and wide perspectives 57
Reproductive Status Is Associated with the Severity of Fibrosis in Women with Hepatitis C 57
Menopause, and not age, is a critical factor associated with a worse response to antiviral therapy in women affected by chronic hepatitis C 56
Worsening of serum lipid profile after direct acting antiviral treatment 56
Study of the serum metabolomic profile in nonalcoholic fatty liver disease: Research and clinical perspectives 56
Impact of hepatitis C virus infection on health-related quality of life before and after liver transplantation: a multidisciplinary point of view 56
Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice 55
Stem cells for end stage liver disease: How far have we got? 55
Liver transplantation from hepatitis B surface antigen positive donors: A safe way to expand the donor pool 55
La prospettiva psicosomatica nella clinica dei trapianti d'organo. 54
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: A single center case-control study 53
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation 52
A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy 52
Serum hepatitis B surface antigen monitoring in long-term lamivudine-treated hepatitis B virus patients 52
Non-alcoholic steatohepatitis and liver transplantation 52
NS5A inhibitors for the treatment of hepatitis C infection 52
Hepatitis C Virus-related chronic liver disease in elderly patients: An Italian cross-sectional study 51
The use of obeticholic acid for the management of non-viral liver disease: current clinical practice and future perspectives 51
Acute abdomen in the immunocompromised patient: WSES, SIS-E, WSIS, AAST, and GAIS guidelines 50
Letter: TNFα inhibitors and prevalence of fatty liver disease in chronic inflammatory diseases 50
Liver transplantation for patients with alcoholic liver disease: An open question 50
Multidisciplinary view of alcohol use disorder: From a psychiatric illness to a major liver disease 49
Influence of age and gender before and after liver transplantation 49
Hepatitis B virus-related cryogobulinemic vasculitis. The role of antiviral nucleot(s)ide analogues: a review 49
Microbiota and viral hepatitis: State of the art of a complex matter 48
Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease article 47
Oxidative stress–induced fibrinogen modifications in liver transplant recipients: unraveling a novel potential mechanism for cardiovascular risk 45
Vitamins in the treatment of chronic viral hepatitis 45
Peginterferon-A-2B plus ribavirin is more effective than peginterferon-A-2A plus ribavirin in menopausal women with chronic hepatitis C 45
The MELD score in patients awaiting liver transplant: Strengths and weaknesses 44
From advanced disease to transplantation: an overview of the liver at the time of COVID-19 pandemic 44
Quality of life of hepatitis B virus surface antigen-positive patients with suppressed viral replication: comparison between inactive carriers and nucleot(s)ide analog-treated patients 43
In response 43
Physical activity in liver transplant recipients: a large multicenter study 43
The Other Side of Malnutrition in Inflammatory Bowel Disease (IBD): Non-Alcoholic Fatty Liver Disease 41
Surgical site infection prevention and management in immunocompromised patients: a systematic review of the literature 39
Virological Treatment Monitoring for Chronic Hepatitis B 38
Impact and Novel Perspective of Immune Checkpoint Inhibitors in Patients with Early and Intermediate Stage HCC 37
Aging with a Liver Graft: Analysis of Very Long-Term Survivors after Liver Transplantation 36
Everolimus Mitigates the Risk of Hepatocellular Carcinoma Recurrence after Liver Transplantation 35
Primary biliary cholangitis associated with SARS-CoV-2 infection 35
Hepatitis C: clinical management and debated issues 35
Metabolic Disorders in Liver Transplant Recipients: The State of the Art 31
Probiotics and the gut-liver axis 30
HBV and HCV testing outcomes among marginalized communities in Italy, 2019–2024: a prospective study 9
Real-world analysis on the use of gamma-hydroxybutyric acid for alcohol withdrawal syndrome in hospitalized patients with diagnosis of cirrhosis 7
Frailty after Liver Transplantation: A Complex Unexplored Issue 6
Immune Checkpoint Inhibitors in the Pre-Transplant Hepatocellular Carcinoma Setting: A Glimpse Beyond the Liver 5
5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial 5
The impact of socioeconomic deprivation on liver transplantation 4
Liver transplantation and nonalcoholic steatohepatitis: the state of the art 3
null 2
Totale 6.407
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.627
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.627
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020352 0 0 0 0 0 0 38 44 39 32 165 34
2020/2021758 106 44 112 54 29 30 27 76 44 173 40 23
2021/2022445 4 28 58 9 13 5 14 38 40 30 60 146
2022/20231.013 102 287 35 37 25 189 143 48 91 9 30 17
2023/2024515 12 32 89 20 29 53 16 128 15 62 38 21
2024/20253.068 155 398 202 502 1.129 611 71 0 0 0 0 0
Totale 6.410